https://iecure.com/wp-content/uploads/endpoint-news.svg
52
280
eallison
/wp-content/uploads/iEcure_logo.png
eallison2021-09-09 08:00:552021-12-30 15:38:36The Tachi Yamada legacy tree continues to grow with a new gene editing biotech from Jim Wilson
/wp-content/uploads/iEcure_logo.png
0
0
David Anderson
/wp-content/uploads/iEcure_logo.png
David Anderson2022-02-01 08:11:062022-02-08 20:32:34iECURE Expands Leadership Team with the Appointment of Mark Semanick as VP and Head of Technical Operations and Brad Dickerson as VP of Project Management & Patient Advocacy
/wp-content/uploads/iEcure_logo.png
0
0
eallison
/wp-content/uploads/iEcure_logo.png
eallison2021-12-16 08:00:052022-05-10 20:07:18iECURE Partners to Develop Next-Generation Liver-Targeted Lipid Nanoparticles with University of Pennsylvania
/wp-content/uploads/iEcure_logo.png
0
0
eallison
/wp-content/uploads/iEcure_logo.png
eallison2021-12-07 12:29:012022-04-07 21:07:47iECURE Bolsters Senior Management Team with Appointment of David Garrett as Chief Financial Officer
/wp-content/uploads/iEcure_logo.png
0
0
eallison
/wp-content/uploads/iEcure_logo.png
eallison2021-09-15 08:00:302022-05-10 20:08:16iECURE Appoints Brian Di Donato to Board of Directors
/wp-content/uploads/iEcure_logo.png
0
0
eallison
/wp-content/uploads/iEcure_logo.png
eallison2021-09-15 08:00:072022-05-10 20:08:59iECURE Launches With $50 Million Series A Financing to Develop In Vivo Gene Insertion Approaches for Devastating Diseases
Scroll to top
